SCHEMBL30620430

SCHEMBL30620430

[2H]c1cnc(NC(C)=O)s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL115951 0.80 — —
Hydrochloric Acid SCHEMBL29059238 0.78 AGER (0.64) —
Hydrochloric Acid SCHEMBL28995499 0.78 AGER (0.64) —
Acetic Acid Methyl Ester SCHEMBL10387561 0.74 AGER (0.59) —
Trifluoroacetic Acid SCHEMBL29366000 0.70 MEN1 (0.58) —
Trifluoroacetic Acid SCHEMBL29744983 0.70 MEN1 (0.58) —
SCHEMBL2656302 0.67 AGER (0.51) —
SCHEMBL31247565 0.67 LMNA (0.44) —
SCHEMBL564354 0.65 — —
SCHEMBL9715384 0.64 HTT (0.61) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4249475-A1 COMPOUND HAVING INHIBITORY ACTIVITY AGAINST O-GLCNACASE AND USE THEREOF MEDIFRON DBT INC. (KR) 2023-09-27 — — EP claimed
Send feedback